575 related articles for article (PubMed ID: 15736440)
21. Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population.
Saxena A; Dhillon VS; Raish M; Asim M; Rehman S; Shukla NK; Deo SV; Ara A; Husain SA
Breast Cancer Res Treat; 2009 Jun; 115(3):537-43. PubMed ID: 18574688
[TBL] [Abstract][Full Text] [Related]
22. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.
Cascorbi I; Roots I; Brockmöller J
Cancer Res; 2001 Jul; 61(13):5051-6. PubMed ID: 11431340
[TBL] [Abstract][Full Text] [Related]
23. Glutathione S-transferase M1, T1 and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk.
Tamer L; Ateş NA; Ateş C; Ercan B; Elipek T; Yildirim H; Camdeviren H; Atik U; Aydin S
Cell Biochem Funct; 2005; 23(4):267-72. PubMed ID: 15473001
[TBL] [Abstract][Full Text] [Related]
24. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
[TBL] [Abstract][Full Text] [Related]
25. GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: a case-control study.
Zupa A; Sgambato A; Bianchino G; Improta G; Grieco V; LA Torre G; Campisi B; Traficante A; Aieta M; Cittadini A
Anticancer Res; 2009 May; 29(5):1709-14. PubMed ID: 19443391
[TBL] [Abstract][Full Text] [Related]
26. Protein carbonyl levels, glutathione S-transferase polymorphisms and risk of colorectal cancer.
Yeh CC; Lai CY; Hsieh LL; Tang R; Wu FY; Sung FC
Carcinogenesis; 2010 Feb; 31(2):228-33. PubMed ID: 19933708
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.
McGrath M; Michaud D; De Vivo I
BMC Cancer; 2006 Oct; 6():239. PubMed ID: 17026750
[TBL] [Abstract][Full Text] [Related]
28. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer.
Bell DA; Stephens EA; Castranio T; Umbach DM; Watson M; Deakin M; Elder J; Hendrickse C; Duncan H; Strange RC
Cancer Res; 1995 Aug; 55(16):3537-42. PubMed ID: 7627961
[TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India.
Srivastava DS; Mandhani A; Mittal B; Mittal RD
BJU Int; 2005 Jan; 95(1):170-3. PubMed ID: 15638917
[TBL] [Abstract][Full Text] [Related]
30. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
[TBL] [Abstract][Full Text] [Related]
31. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
[TBL] [Abstract][Full Text] [Related]
32. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer.
Lee KM; Park SK; Kim SU; Doll MA; Yoo KY; Ahn SH; Noh DY; Hirvonen A; Hein DW; Kang D
Cancer Lett; 2003 Jul; 196(2):179-86. PubMed ID: 12860276
[TBL] [Abstract][Full Text] [Related]
33. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
[TBL] [Abstract][Full Text] [Related]
34. [Associations between genetic polymorphisms of glutathione S-transferase M1 and T1, smoking and susceptibility to colorectal cancer: a case-control study].
Chen K; Jiang QT; Ma XY; Yao KY; Leng SG; Yu WP; Zhou HG
Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):645-8. PubMed ID: 15777499
[TBL] [Abstract][Full Text] [Related]
35. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
36. Genotype and allele frequencies of N-acetyltransferase 2 and glutathione S-transferase in the Iranian population.
Torkaman-Boutorabi A; Hoormand M; Naghdi N; Bakhshayesh M; Milanian I
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1207-11. PubMed ID: 17880378
[TBL] [Abstract][Full Text] [Related]
37. p53 mutations in bladder cancer: evidence for exogenous versus endogenous risk factors.
Schroeder JC; Conway K; Li Y; Mistry K; Bell DA; Taylor JA
Cancer Res; 2003 Nov; 63(21):7530-8. PubMed ID: 14612556
[TBL] [Abstract][Full Text] [Related]
38. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans.
Martínez C; Martín F; Fernández JM; García-Martín E; Sastre J; Díaz-Rubio M; Agúndez JA; Ladero JM
Pharmacogenomics; 2006 Jul; 7(5):711-8. PubMed ID: 16886896
[TBL] [Abstract][Full Text] [Related]
39. Impact of GSTT1, GSTM1, GSTP1 and NAT2 genotypes on KRAS2 and TP53 gene mutations in colorectal cancer.
Ferraz JM; Zinzindohoué F; Lecomte T; Cugnenc PH; Loriot MA; Beaune P; Stücker I; Berger A; Laurent-Puig P
Int J Cancer; 2004 Jun; 110(2):183-7. PubMed ID: 15069679
[TBL] [Abstract][Full Text] [Related]
40. No association between genetic polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and nasopharyngeal carcinoma in Taiwan.
Cheng YJ; Chien YC; Hildesheim A; Hsu MM; Chen IH; Chuang J; Chang J; Ma YD; Luo CT; Hsu WL; Hsu HH; Huang H; Chang JF; Chen CJ; Yang CS
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):179-80. PubMed ID: 12582034
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
